Traynor Capital Management’s CVS Health CVS Stock Holding History

Traynor Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,000	Closed	-$93.2K	–	220
2022 Q4	$93.2K	Buy	+1,000	New	+$96.5K	0.01%	190

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Traynor Capital Management's CVS Position: Q1 2023 in Review

Traynor Capital Management sold out of CVS Health (CVS) in Q1 2023, closing a stake of 1,754 shares — an estimated $163K sold.

Traynor Capital Management first reported a position in CVS in Q4 2014 and held it in 23 quarters. The position peaked at $721K in Q2 2020. 2,268 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

Traynor Capital Management reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
Traynor Capital Management sold 1,754 CVS Health shares in Q1 2023, an estimated $163K.
Traynor Capital Management first reported a position in CVS Health in Q4 2014 and held it in 23 quarters.
Traynor Capital Management's CVS Health position peaked at $721K in Q2 2020.
2,268 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Traynor Capital Management's 13F filing for Q1 2023, filed 21 Apr 2023.